Werden Sie mit Ihrer Handelsstrategie der Trader 2026 und gewinnen Sie einen Range Rover Evoque. Hier anmelden!
| Geld/Brief | 29,17 $ / 86,90 $ |
| Spread | +197,91% |
| Schluss Vortag | 74,14 $ |
| Gehandelte Stücke | 90.536 |
| Tagesvolumen Vortag | 2.512.552 $ |
| Tagestief 69,42 $ Tageshoch 74,69 $ | |
| 52W-Tief 40,01 $ 52W-Hoch 98,96 $ | |
| Jahrestief 40,01 $ Jahreshoch 83,84 $ | |
| Umsatz in Mio. | - |
| Operatives Ergebnis (EBIT) in Mio. | -236,02 $ |
| Jahresüberschuss in Mio. | -212,18 $ |
| Umsatz je Aktie | - |
| Gewinn je Aktie | -6,01 $ |
| Gewinnrendite | - |
| Umsatzrendite | - |
| Return on Investment | -26,30% |
| Marktkapitalisierung in Mio. | 3.042 $ |
| KGV (Kurs/Gewinn) | -13,21 |
| KBV (Kurs/Buchwert) | 3,79 |
| KUV (Kurs/Umsatz) | - |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | +91,69% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| AMEX | 73,95 $ | +0,19% | 73,81 $ | 11.09.26 | |
| Nasdaq | 70,04 $ | -5,53% | 74,14 $ | 11.09.26 | |
| NYSE | 69,97 $ | -5,70% | 74,20 $ | 11.09.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 10.09.26 | 74,14 | 2,87 M |
| 09.09.26 | 76,51 | 3,69 M |
| 08.09.26 | 76,84 | 2,10 M |
| 04.09.26 | 79,23 | 1,56 M |
| 03.09.26 | 79,37 | 3,68 M |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 79,23 $ | -6,32% |
| 1 Monat | 81,21 $ | -8,61% |
| 6 Monate | 63,85 $ | +16,24% |
| 1 Jahr | 60,29 $ | +23,10% |
| 5 Jahre | - | - |
| Marktkapitalisierung | 3,04 Mrd. $ |
| Streubesitz | -7,32% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | Stammaktie |
| +14,63% | FMR Inc |
| +5,96% | BlackRock Inc |
| +5,17% | RA Capital Management, LLC |
| +4,75% | Strategic Advisers Fidelity US TtlStk |
| +4,63% | Vanguard Group Inc |
| +4,54% | Wellington Management Company LLP |
| +4,45% | State Street Corp |
| +4,06% | T. Rowe Price Associates, Inc. |
| +3,96% | Atlas Venture Life Science Advisors, LLC |
| +3,60% | Vanguard Capital Management, LLC |
| +3,59% | JPMorgan Chase & Co |
| +3,55% | Frazier Life Sciences Management, L.P. |
| +3,51% | TCG Crossover Management, LLC |
| +3,33% | Bvf Inc |
| +2,96% | State Street® SPDR® S&P® Biotech ETF |
| +2,79% | Orbimed Advisors, LLC |
| +2,78% | Orbimed Advisors LLC |
| +2,60% | Vanguard Total Stock Mkt Idx Inv |
| +2,59% | Siren, L.L.C. |
| +2,54% | Vanguard MStar Total Stk Mkt Idx Invest |
| +2,54% | Vanguard Morn Total Stk Mkt Idx Investor |
| +2,51% | Woodline Partners LP |
| +2,23% | Opaleye Management Inc |
| +1,95% | Geode Capital Management, LLC |
| +1,92% | Vestal Point Capital LP |
| +1,72% | Deerfield Management Co |
| +1,70% | Fidelity Select Health Care |
| +1,69% | iShares Russell 2000 ETF |
| +1,68% | The Goldman Sachs Group Inc |
| +1,60% | Jennison Associates LLC |
| +1,47% | Logos Global Management LP |
| +1,39% | Fidelity Select Biotechnology |
| +1,32% | US Small-Cap Growth II Equity Comp |
| +1,32% | T. Rowe Price New Horizons |
| +1,04% | Fidelity Small Cap Growth |
| +1,03% | Eventide Healthcare & Life Sciences I |
| +1,01% | JPMorgan Mid Cap Growth I |
| +1,01% | JPM US Mid Cap Growth-Composite |
| +1,01% | MEDICAL BioHealth EUR Acc |
| +0,94% | Vanguard Institutional Extnd Mkt Idx Tr |
| +0,86% | Fidelity Advisor Health Care I |
| +0,83% | T. Rowe Price Integrated US Sm Gr Eq |
| +0,83% | T. Rowe Price Integrated US SmCapGrEq |
| +0,76% | JPMorgan Small Cap Growth A |
| +0,72% | JPM US Mid Cap Growth-MA |
| +0,71% | Fidelity Small Cap Index |
| +0,71% | Fidelity Stock Selector Small Cap |
| +0,68% | iShares Russell 2000 Growth ETF |
| +0,66% | T. Rowe Price New Horizons Tr-A |
| +0,65% | Pictet-Biotech P USD |
| +99,523% | Institutionelle Aktionäre |
| +7,792% | Insider Aktionäre |
| -7,315% | Streubesitz |
